ZNTL Financial Statements

Balance sheet, income statement, cash flow, and dividends for Zentalis Pharmaceuticals Inc (ZNTL).


$215.93M Market Cap.

As of 03/26/2025 5:00 PM ET (MRY) • Disclaimer

ZNTL Market Cap. (MRY)


ZNTL Shares Outstanding (MRY)


ZNTL Assets (MRY)


Total Assets

$430.34M

Total Liabilities

$93.15M

Total Investments

$337.18M

ZNTL Income (MRY)


Revenue

$0

Net Income

-$165.84M

Operating Expense

$258.62M

ZNTL Cash Flow (MRY)


CF Operations

-$170.86M

CF Investing

$176.56M

CF Financing

$108.00K

ZNTL Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ZNTL Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$430,337,000 (-22.00%)

$551,688,000 (2.30%)

$539,310,000 (18.66%)

$454,507,000 (24.33%)

Assets Current

$386,066,000 (-22.28%)

$496,718,000 (9.91%)

$451,933,000 (28.84%)

$350,770,000 (1.64%)

Assets Non-Current

$44,271,000 (-19.46%)

$54,970,000 (-37.09%)

$87,377,000 (-15.77%)

$103,737,000 (407.25%)

Goodwill & Intangible Assets

$0 (0%)

$3,736,000 (0.00%)

$3,736,000 (0.00%)

$3,736,000 (0.00%)

Shareholders Equity

$337,186,000 (-22.89%)

$437,284,000 (0.80%)

$433,803,000 (19.19%)

$363,954,000 (17.94%)

Property Plant & Equipment Net

$37,227,000 (-10.80%)

$41,735,000 (-16.66%)

$50,078,000 (-5.23%)

$52,839,000 (1360.04%)

Cash & Equivalents

$36,528,000 (18.91%)

$30,719,000 (-32.78%)

$45,696,000 (-26.98%)

$62,584,000 (11.22%)

Accumulated Other Comprehensive Income

$558,000 (-74.57%)

$2,194,000 (262.16%)

-$1,353,000 (-982.40%)

-$125,000 (-447.22%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$337,183,000 (-25.87%)

$454,881,000 (9.47%)

$415,515,000 (30.80%)

$317,668,000 (12.03%)

Investments Current

$337,183,000 (-25.87%)

$454,881,000 (15.36%)

$394,302,000 (40.74%)

$280,173,000 (-1.19%)

Investments Non-Current

$0 (0%)

$0 (0%)

$21,213,000 (-43.42%)

$37,495,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$5,000,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$7,438,000 (-50.17%)

$14,926,000 (32.71%)

$11,247,000 (-2.96%)

$11,590,000 (33.82%)

Accumulated Retained Earnings (Deficit)

-$1,054,395,000 (-18.66%)

-$888,556,000 (-49.00%)

-$596,365,000 (-65.86%)

-$359,559,000 (-79.03%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$853,000 (-47.41%)

$1,622,000 (-34.60%)

Total Debt

$39,577,000 (-8.28%)

$43,150,000 (-4.46%)

$45,166,000 (1.59%)

$44,459,000 (3952.78%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$39,577,000 (-8.28%)

$43,150,000 (-4.46%)

$45,166,000 (1.59%)

$44,459,000 (3952.78%)

Total Liabilities

$93,151,000 (-18.50%)

$114,297,000 (8.56%)

$105,286,000 (16.95%)

$90,025,000 (179.77%)

Liabilities Current

$52,725,000 (-23.99%)

$69,367,000 (22.45%)

$56,647,000 (28.91%)

$43,944,000 (53.64%)

Liabilities Non-Current

$40,426,000 (-10.02%)

$44,930,000 (-7.63%)

$48,639,000 (5.55%)

$46,081,000 (1188.26%)

ZNTL Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$87,115,000 (35.37%)

$64,351,000 (17.96%)

$54,553,000 (33.25%)

$40,941,000 (20.82%)

Research & Development Expense

$167,768,000 (-28.66%)

$235,158,000 (36.14%)

$172,734,000 (-1.63%)

$175,601,000 (106.83%)

Operating Expenses

$258,619,000 (-13.65%)

$299,509,000 (31.78%)

$227,287,000 (4.96%)

$216,542,000 (82.29%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$177,000 (129.45%)

-$601,000 (-28.14%)

-$469,000 (-57.91%)

-$297,000 (-166.89%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$165,867,000 (43.26%)

-$292,305,000 (-23.28%)

-$237,113,000 (-42.76%)

-$166,093,000 (-40.11%)

Net Income to Non-Controlling Interests

-$28,000 (75.44%)

-$114,000 (62.87%)

-$307,000 (95.83%)

-$7,368,000 (-942.15%)

Net Income

-$165,839,000 (43.24%)

-$292,191,000 (-23.39%)

-$236,806,000 (-49.19%)

-$158,725,000 (-34.69%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$165,839,000 (43.24%)

-$292,191,000 (-23.39%)

-$236,806,000 (-49.19%)

-$158,725,000 (-34.69%)

Weighted Average Shares

$71,080,000 (8.67%)

$65,409,000 (23.75%)

$52,857,000 (23.82%)

$42,688,000 (51.84%)

Weighted Average Shares Diluted

$71,080,000 (8.67%)

$65,409,000 (23.75%)

$52,857,000 (23.82%)

$42,688,000 (51.84%)

Earning Before Interest & Taxes (EBIT)

-$165,662,000 (43.42%)

-$292,792,000 (-23.40%)

-$237,275,000 (-49.21%)

-$159,022,000 (-35.46%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$258,619,000 (13.65%)

-$299,509,000 (-31.78%)

-$227,287,000 (-4.96%)

-$216,542,000 (-82.29%)

ZNTL Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$176,561,000 (497.14%)

-$44,458,000 (61.06%)

-$114,180,000 (-530.31%)

-$18,115,000 (93.64%)

Net Cash Flow from Financing

$108,000 (-99.95%)

$237,303,000 (-9.09%)

$261,043,000 (46.23%)

$178,521,000 (-50.47%)

Net Cash Flow from Operations

-$170,860,000 (17.79%)

-$207,822,000 (-26.91%)

-$163,751,000 (-6.27%)

-$154,093,000 (-77.48%)

Net Cash Flow / Change in Cash & Cash Equivalents

$5,809,000 (138.79%)

-$14,977,000 (11.32%)

-$16,888,000 (-367.51%)

$6,313,000 (156.28%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

-$14,320,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$176,717,000 (502.77%)

-$43,875,000 (60.70%)

-$111,632,000 (-4928.37%)

$2,312,000 (100.81%)

Capital Expenditure

-$156,000 (73.24%)

-$583,000 (77.12%)

-$2,548,000 (58.28%)

-$6,107,000 (-705.67%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$108,000 (-99.95%)

$237,303,000 (-9.09%)

$261,043,000 (46.23%)

$178,521,000 (-45.54%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$67,269,000 (22.70%)

$54,822,000 (17.04%)

$46,840,000 (31.07%)

$35,737,000 (54.40%)

Depreciation Amortization & Accretion

$1,289,000 (-7.20%)

$1,389,000 (-2.59%)

$1,426,000 (162.13%)

$544,000 (240.00%)

ZNTL Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-43.30% (32.24%)

-63.90% (-11.32%)

-57.40% (-12.99%)

-50.80% (17.40%)

Return on Average Assets (ROAA)

-34.40% (33.85%)

-52.00% (-12.07%)

-46.40% (-9.69%)

-42.30% (0.94%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-39.10% (42.58%)

-68.10% (-21.17%)

-56.20% (-5.24%)

-53.40% (21.12%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.3 (61.64%)

-3.39 (24.62%)

-4.5 (80.10%)

-22.6 (-82.29%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.64 (-73.90%)

2.45 (-7.47%)

2.65 (-74.68%)

10.46 (53.07%)

Debt to Equity Ratio (D/E)

0.28 (5.75%)

0.26 (7.41%)

0.24 (-1.62%)

0.25 (137.50%)

Earnings Per Share (EPS)

-2.33 (47.87%)

-4.47 (0.22%)

-4.48 (-20.43%)

-3.72 (11.22%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-2.41 (24.48%)

-3.19 (-1.27%)

-3.15 (16.17%)

-3.75 (-20.48%)

Book Value Per Share (BVPS)

4.74 (-29.04%)

6.68 (-18.55%)

8.21 (-3.74%)

8.53 (-22.32%)

Tangible Assets Book Value Per Share (TABVPS)

6.05 (-27.73%)

8.38 (-17.33%)

10.13 (-4.04%)

10.56 (-17.95%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (66.67%)

-3 (40.00%)

-5 (79.17%)

-24 (-41.18%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.29 (62.43%)

-3.44 (26.55%)

-4.68 (80.29%)

-23.75 (-38.16%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

7.32 (2.25%)

7.16 (-10.24%)

7.98 (-0.05%)

7.98 (-33.85%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$171,016,000 (17.94%)

-$208,405,000 (-25.32%)

-$166,299,000 (-3.81%)

-$160,200,000 (-82.91%)

Enterprise Value (EV)

$212,444,162 (-78.80%)

$1,001,989,431 (-9.26%)

$1,104,201,549 (-70.67%)

$3,764,313,029 (86.76%)

Earnings Before Tax (EBT)

-$165,662,000 (43.42%)

-$292,792,000 (-23.40%)

-$237,275,000 (-49.21%)

-$159,022,000 (-35.46%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$164,373,000 (43.59%)

-$291,403,000 (-23.55%)

-$235,849,000 (-48.82%)

-$158,478,000 (-35.18%)

Invested Capital

$380,661,000 (-22.47%)

$491,016,000 (2.64%)

$478,397,000 (23.08%)

$388,702,000 (39.80%)

Working Capital

$333,341,000 (-22.00%)

$427,351,000 (8.11%)

$395,286,000 (28.83%)

$306,826,000 (-3.06%)

Tangible Asset Value

$430,337,000 (-21.46%)

$547,952,000 (2.31%)

$535,574,000 (18.81%)

$450,771,000 (24.58%)

Market Capitalization

$215,934,162 (-79.86%)

$1,072,101,431 (-6.72%)

$1,149,379,549 (-69.82%)

$3,808,384,029 (80.54%)

Average Equity

$383,217,250 (-16.13%)

$456,920,000 (10.76%)

$412,523,750 (32.05%)

$312,404,250 (62.93%)

Average Assets

$482,539,250 (-14.15%)

$562,047,250 (10.10%)

$510,509,000 (35.96%)

$375,475,750 (36.09%)

Invested Capital Average

$423,349,000 (-1.54%)

$429,967,000 (1.93%)

$421,835,750 (41.75%)

$297,584,000 (71.48%)

Shares

71,265,400 (0.71%)

70,765,771 (24.00%)

57,069,491 (25.97%)

45,305,544 (11.55%)